When considering biologic therapy for your moderate to severe Crohn’s patients, choose CIMZIA. When considering biologic therapy for your moderate to severe Crohn’s patients, choose CIMZIA.

When considering biologic therapy for your moderate to severe Crohn’s patients, choose CIMZIA first (when conventional therapy is not enough). Three clinical reasons to choose CIMZIA

Disease Progression Reference: (5) Data on file. UCB, Inc.; Smyrna, GA.
Response & Remission References: (1) CIMZIA® [prescribing information], Smyrna, GA: UCB, Inc.; 2013. (14) Schreiber S, Khaliq-Kareemi M, Lawrance IC, et al. Maintenance therapy with certolizumab pegol for Crohn’s disease. N Engl J Med. 2007;357:239-250.
Quality of Life Reference: (5) Data on file. UCB, Inc.; Smyrna, GA.